Chloramphenicol-Associated Aplastic Anemia

Rappeport JM Bunn HF . Bone marrow failure: Aplastic anemia and other primary bone marrow disorders. In: Braunwald E Isselbacher KJ Petersdorf RC eds. Harrison's principles of internal medicine. 11th ed. New York: McGraw-Hill, 1987: 1533–6.

Jadarji T Humphreys RP Prober CB . Brain abcesses in infants and children. Pediatr Infect Dis 1985; 4: 394–8.

McEvoy GK McQuarrie GM , eds. American hospital formulary service: Drug information 87. Bethesda, MD: American Society of Hospital Pharmacists, 1987: 169–72.

Bottiger LE . Drug-induced aplastic anemia and agranulocytosis: Incidence and mechanisms. Drugs 1986; 31: 52–63.

Leiken SL Welch H Guin GH . Aplastic anemia due to chloramphenicol. Clin Proc Child Hosp 1961; 17: 899–914.

Swanson M Cook R . Drugs chemicals and blood dyscrasias. Hamilton, IL: Drug Intelligence Publications, 1977: 1120–1.

Aksoy M Erdem S Dincol G Bakioglu I Kutlar A . Aplastic anemia due to chemicals and drugs: A study of 108 patients. Sex Transm Dis 1984; 11 (4 suppl): 347–50.

McGuinness R . Chloramphenicol eye drops and blood dyscrasia. Med J Aust 1984; 140: 383.

Alavi JB . Aplastic anemia associated with intravenous chloramphenicol. Am J Hematol 1983; 15: 375–9.

Fraunfelder FT Bagby GC Jr Kelly DJ . Fatal aplastic anemia following topical administration of ophthalmic chloramphenicol. Am J Ophthalmol 1982; 93: 356–60.

Schmitt-Graff A . Chloramphenicol-induced aplastic anemia terminating with acute nonlymphocytic leukemia. Acta Haematol (Basel) 1981; 66: 267–8.

Farber BF Brody JP . Rapid development of aplastic anemia after intravenous chloramphenicol and cimetidine therapy. South Med J 1981; 74: 1257–8.

Del Giacco GS Petrini MT Jannelli S Carcassi U . Fatal bone marrow hypoplasia in a shepherd using chloramphenicol spray (letter). Lancet 1981; 1: 945.

Abrams SM Degnan TJ Vinciguerra V . Marrow aplasia following topical application of chloramphenicol eye ointment. Arch Intern Med 1980; 140: 576–7.

Ellims PH VanderWeyden MB Brodie GN Firkin BG White-Side MG Faragher BS . Erythroleukemia following drug induced hypoplastic anemia. Cancer 1979; 44: 2140–6.

Daum RS Cohen DL Smith AL . Fatal aplastic anemia following apparent “dose-related” chloramphenicol toxicity. J Pediatr 1979; 94: 403–6.

Al-Mindhiry HA . Aplastic anaemia in Iraq. A prospective study. Haematologia (Budap) 1978–79; 12: 159–64.

Yoshimatsu H Uetake S Miyao S . A retrospective survey of drugs and chemicals associated with the development of aplastic anemia. In: Hibino S Takaku F Shahidi N , ed. Aplastic anemia. Baltimore: University Park Press, 1978: 189–96.

Suda T Omine M Tsuchiya J Maekawa T . Prognostic aspects of aplastic anemia in pregnancy. Experience on six cases and review of the literature. Blut 1978; 36: 285–98.

Haile CA . Chloramphenicol toxicity. South Med J 1977; 70: 479–80.

Carpenter G . Chloramphenicol eye-drops and marrow aplasia. Lancet 1975; 2: 326–7.

Hellriegel KP Gross R . Follow-up studies in chloramphenicol-induced aplastic anaemia. Postgrad Med J 1974; 50 (suppl 5): 136–42.

Cohen HJ Huang AT . A marker chromosome abnormality. Occurrence in chloramphenicol-associated acute leukemia. Arch Intern Med 1973; 132: 440–3.

Meyer JS Boxer M . Leukemic cellular thrombi in pulmonary blood vessels. Subleukemic myelogenous leukemia following chloramphenicol-induced aplastic anemia. Cancer 1973; 32: 712–21.

Bottiger LE Westerholm B . Drug induced blood dyscrasias in Sweden. Br Med J 1973; 3: 339–43.

Hodgkinson R . The chloramphenicol-hepatitis-aplastic anaemia syndrome. Med J Aust 1973; 1: 939–40.

Bottiger LE Westerholm B . Aplastic anaemia. III. Aplastic anaemia and infectious hepatitis. Acta Med Scand 1972; 192: 323–6.

King JB Burns DG . Aplastic anaemia, oxymetholone and acute myeloid leukaemia. S Afr Med J 1972; 46: 1622–3.

Hodgkinson R . Infectious hepatitis and aplastic anaemia (letter). Lancet 1971; 1: 1014.

Amir J . Chloramphenicol—refutation from Israel. N Engl J Med 1970; 282: 1047.

Shepard NJ Samaras NG . Chloramphenicol-induced aplastic anemia. Oral Surg Oral Med Oral Pathol 1970; 29: 689–93.

Edwards LD . Association between chloramphenicol, hypoplastic anemia and acute myeloblastic leukemia: A case report. Milit Med 1969; 134: 1447–9.

Mork JN Thalhuber WH Swaim WR . Hematologic toxicity of chloramphenicol. Minn Med 1969; 68: 1619–20.

Seaman AJ . Sequels to chloramphenicol aplastic anemia: Acute leukemia and paroxysmal nocturnal hemoglobinuria. Northwest Med 1969; 68: 831–4.

Nagao T Mauer AM . Concordance for drug-induced aplastic anemia in identical twins. N Engl J Med 1969; 281: 7–11.

Wallerstein RO Condit PK Kasper CK Brown JW Morrison FR . Statewide study of chloramphenicol therapy and fatal aplastic anemia. JAMA 1969; 208: 2045–50.

Nora AH Fernbach DJ . Acquired aplastic anemia in children. Tex Med 1969; 65: 38–43.

Brauer MJ Dameshek W . Hypoplastic anemia and myeloblastic leukemia following chloramphenicol therapy. Report of three cases. N Engl J Med 1967; 277: 1003–5.

Cohen T Creger WP . Acute myeloid leukemia following seven years of aplastic anemia induced by chloramphenicol. Am J Med 1967; 43: 762–70.

Fraumen JF . Bone marrow depression induced by chloramphenicol or phenylbutazone. JAMA 1967; 201: 828–34.

Beckman H . Aplastic anemia. Wis Med J 1967; 66: 422–6.

Das PK Chatterjee SC . Bone marrow depression due to chloramphenicol. J Indian Med Assoc 1967; 48: 231–2.

Pegg DE Burns JE . A sex-dependent factor in aplastic anaemia? Nature 1965; 208: 1187–8.

Best WR . Chloramphenicol-associated blood dyscrasias. JAMA 1967; 201: 828–34.

Modan B Segal S Shani M . Aplastic anemia in Israel: Evaluation of the etiological role of chloramphenicol on a community-wide basis. Am J Med Sci 1975; 270: 441–5.

Keiser G Buchegger U . Hematological side effects of chloramphenicol and thiamphenicol. Helv Med Acta 1973; 37: 265–79.

Smick KM Condit PK Proctor RL . Fatal aplastic anemia—an epidemiological study of its relationship to the drug chloramphenicol. J Chronic Dis 1964; 17: 899–914.

Abe T Komiya M . Some clinical aspects of aplastic anemia. In: Hibino S Takaku F Shahidi N , eds. Aplastic anemia. Baltimore: University Park Press, 1978: 197–206.

Whang KS . Aplastic anemia in Korea: A clinical study of 309 cases. In: Hibino S Takaku F Shahidi N , eds. Aplastic anemia. Baltimore: University Park Press, 1978: 225–42.

Khosla SN Chopra JS Arora BS . Aplastic anemia: A clinical study. J Assoc Physicians India 1972; 20: 745–9.

Polak BC Wesseling H Schut D . Blood dyscrasias attributed to chloramphenicol. A review of 576 published and unpublished cases. Acta Med Scand 1972; 192: 409–14.

Vincent PC . Drug-induced aplastic anemia and agranulocytosis, incidence and mechanisms. Drugs 1986; 31: 52–63.

Yunis AA . Chloramphenicol toxicity. In: Girdwood RH , ed. Blood disorders due to drugs and other agents. Amsterdam: Excerpta Medica, 1974: 107–26.

Yunis AA Miller AM Salem Z . Chloramphenicol toxicity: Pathogenetic mechanisms and the role of the p-NO₂ in aplastic anemia. Clin Toxicol 1980; 17: 359–73.

Salem Z Murray T Yunis AA . The nitroreduction of chloramphenicol by human liver tissue. J Lab Clin Med 1981; 97: 881–6.

Lepow ML . Aplastic anemia following chloramphenicol therapy still happens! Pediatrics 1986; 77: 932–3.

Yunis AA Bloomberg GR . Chloramphenicol toxicity: Clinical features and pathogenesis. Prog Hematol 1964; 4: 138–59.

Polin HB Plaut ME . Chloramphenicol. NY State J Med 1977; 77: 378–81.

Fink TJ Gump DW . Chloramphenicol: An inpatient study of use and abuse. J Infect Dis 1978; 138: 690–4.